H2AX haploinsufficiency modifies genomic stability and tumor susceptibility

Cell

Volumn 114, Issue 3, 2003, Pages 371-383

  Celeste, Arkady ^a   Difilippantonio, Simone ^a   Difilippantonio, Michael J ^a   Fernandez Capetillo, Oscar ^a   Pilch, Duane R ^a   Sedelnikova, Olga A ^a   Eckhaus, Michael ^b   Ried, Thomas ^a   Bonner, William M ^a   Nussenzweig, André ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUTAMIC ACID; HISTONE H2A; HISTONE H2AX; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P53; SERINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLONAL VARIATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE LOSS; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC STABILITY; HAPLOIDY; HETEROZYGOTE; HOMOZYGOTE; LYMPHOMA; MOUSE; NONHUMAN; NULL ALLELE; ONCOGENE C MYC; PHOSPHORYLATION; PRIORITY JOURNAL; RADIOSENSITIVITY; WILD TYPE;

ANIMALIA;

EID: 0042991383     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00567-1     Document Type: Article

References (62)

1. Agrawal A., Schatz D.G. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell. 89:1997;43-53.
2. Alt J.R., Greiner T.C., Cleveland J.L., Eischen C.M. Mdm2 haploinsufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J. 22:2003;1442-1450.
3. Bai F., Pei X.H., Godfrey V.L., Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell. Biol. 23:2003;1269-1277.
4. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice. a paradigm of ataxia telangiectasia Cell. 86:1996;159-171.
5. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K.et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. USA. 99:2002;8173-8178. a.
6. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109:2002;S45-S55. b.
7. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W. Histone H2AX. a dosage-dependent suppressor of oncogenic translocations and tumors Cell. 114:2003;359-370., this issue.
8. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J.et al. Genomic instability in mice lacking histone H2AX. Science. 296:2002;922-927.
9. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5:2003;675-679.
10. Chen H.T., Bhandoola A., Difilippantonio M.J., Zhu J., Brown M.J., Tai X., Rogakou E.P., Brotz T.M., Bonner W.M., Ried T., Nussenzweig A. Response to RAG-mediated VDJ cleavage by NBS1 and g-H2AX. Science. 290:2000;1962-1965.
11. Cook W.D., McCaw B.J. Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene. 19:2000;3434-3438.
12. Coquelle A., Pipiras E., Toledo F., Buttin G., Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell. 89:1997;215-225.
13. Desiderio S., Lin W.C., Li Z. The cell cycle and V(D)J recombination. Curr. Top. Microbiol. Immunol. 217:1996;45-59.
14. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature. 404:2000;510-514.
15. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196:2002;469-480.
16. Downs J.A., Lowndes N.F., Jackson S.P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature. 408:2000;1001-1004.
17. Essers J., Hendriks R.W., Swagemakers S.M., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H., Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
18. Fernandez-Capetillo O., Chen H.T., Celeste A., Ward I., Romanienko P.J., Morales J.C., Naka K., Xia Z., Camerini-Otero R.D., Motoyama N.et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4:2002;993-997.
19. Fernandez-Capetillo O., Mahadevaiah S.K., Celeste A., Romanienko P.J., Camerini-Otero R.D., Bonner W.M., Manova K., Burgoyne P., Nussenzweig A. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell. 4:2003;497-508.
20. Fero M.L., Randel E., Gurley K.E., Roberts J.M., Kemp C.J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 396:1998;177-180.
21. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell. 5:2000;993-1002.
22. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination. complexes, ends, and transposition Annu. Rev. Immunol. 18:2000;495-527.
23. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature. 404:2000;897-900.
24. Gladdy R.A., Taylor M.D., Williams C.J., Grandal I., Karaskova J., Squire J.A., Rutka J.T., Guidos C.J., Danska J.S. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell. 3:2003;37-50.
25. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956.
26. Goss K.H., Risinger M.A., Kordich J.J., Sanz M.M., Straughen J.E., Slovek L.E., Capobianco A.J., German J., Boivin G.P., Groden J. Enhanced tumor formation in mice heterozygous for Blm mutation. Science. 297:2002;2051-2053.
27. Gruber S.B., Ellis N.A., Scott K.K., Almog R., Kolachana P., Bonner J.D., Kirchhoff T., Tomsho L.P., Nafa K., Pierce H.et al. BLM heterozygosity and the risk of colorectal cancer. Science. 297:2002;2013. Erratum: Science 297(5594), 2002.
28. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T., Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10:1996;2038-2054.
29. Hiom K., Gellert M. Assembly of a 12/23 paired signal complex. a critical control point in V(D)J recombination Mol. Cell. 1:1998;1011-1019.
30. Inoue K., Zindy F., Randle D.H., Rehg J.E., Sherr C.J. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev. 15:2001;2934-2939.
31. Karanjawala Z.E., Grawunder U., Hsieh C.L., Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9:1999;1501-1504.
32. Kinzler K.W., Vogelstein B. Gatekeepers and caretakers. Nature. 386:1997;761-763.
33. Knudson A.G. Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45:1985;1437-1443.
34. Lim D.S., Vogel H., Willerford D.M., Sands A.T., Platt K.A., Hasty P. Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol. 20:2000;3772-3780.
35. Liyanage M., Coleman A., du Manoir S., Veldman T., McCormack S., Dickson R.B., Barlow C., Wynshaw-Boris A., Janz S., Wienberg J.et al. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet. 14:1996;312-315.
36. Lou Z., Minter-Dykhouse K., Wu X., Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 421:2003;957-961.
37. Magee J.A., Abdulkadir S.A., Milbrandt J. Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell. 3:2003;273-283.
38. Mahadevaiah S.K., Turner J.M., Baudat F., Rogakou E.P., de Boer P., Blanco-Rodriguez J., Jasin M., Keeney S., Bonner W.M., Burgoyne P.S. Recombinational DNA double-strand breaks in mice precede synapsis. Nat. Genet. 27:2001;271-276.
39. Mak T.W., Hakem A., McPherson J.P., Shehabeldin A., Zablocki E., Migon E., Duncan G.S., Bouchard D., Wakeham A., Cheung A.et al. Brcal required for T cell lineage development but not TCR loci rearrangement. Nat. Immunol. 1:2000;77-82.
40. Monni O., Knuutila S. 11q deletions in hematological malignancies. Leuk. Lymphoma. 40:2001;259-266.
41. Nacht M., Strasser A., Chan Y.R., Harris A.W., Schlissel M., Bronson R.T., Jacks T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10:1996;2055-2066.
42. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
43. Pâques F., Haber J.E. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63:1999;349-404.
44. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
45. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R.et al. AID is required to initiate Nbs1/g-H2AX focus formation and mutations at sites of class switching. Nature. 414:2001;660-665.
46. Quon K.C., Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev. 15:2001;2917-2921.
47. Rappold I., Iwabuchi K., Date T., Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153:2001;613-620.
48. Redon C., Pilch D., Rogakou E., Sedelnikova O., Newrock K., Bonner W.M. Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 12:2002;162-169.
49. Reina-San-Martin B., Difilippantonio S., Hanitsch L., Masilamani R.F., Nussenzweig A., Nussenzweig M.C. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197:2003;1767-1778.
50. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:1998;5858-5868.
51. Schultz L.B., Chehab N.H., Malikzay A., Halazonetis T.D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151:2000;1381-1390.
52. Sharpless N.E., Ferguson D.O., O'Hagan R.C., Castrillon D.H., Lee C., Farazi P.A., Alson S., Fleming J., Morton C.C., Frank K.M.et al. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol. Cell. 8:2001;1187-1196.
53. Sonoda E., Sasaki M.S., Buerstedde J.M., Bezzubova O., Shinohara A., Ogawa H., Takata M., Yamaguchi-Iwai Y., Takeda S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:1998;598-608.
54. Stankovic T., Stewart G.S., Byrd P., Fegan C., Moss P.A., Taylor A.M. ATM mutations in sporadic lymphoid tumours. Leuk. Lymphoma. 43:2002;1563-1571.
55. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966.
56. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:1998;5497-5508.
57. Vanasse G.J., Halbrook J., Thomas S., Burgess A., Hoekstra M.F., Disteche C.M., Willerford D.M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 103:1999;1669-1675.
58. Venkatachalam S., Shi Y.P., Jones S.N., Vogel H., Bradley A., Pinkel D., Donehower L.A. Retention of wild-type p53 in tumors from p53 heterozygous mice. reduction of p53 dosage can promote cancer formation EMBO J. 17:1998;4657-4667.
59. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276:2001;47759-47762.
60. Weaver Z.A., McCormack S.J., Liyanage M., du Manoir S., Coleman A., Schrock E., Dickson R.B., Ried T. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Genes Chromosomes Cancer. 25:1999;251-260.
61. -/- mice. Mol. Cell. Biol. 18:1998;4385-4390.
62. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109:2002;811-821.